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DObjective: Surgical repair of total anomalous pulmonary venous connection is associated with significant mor-
tality and morbidity, especially in patients with single-ventricle physiology. This study analyzes total anomalous
pulmonary venous connection surgical repair results at one institution to identify trends and indicators of positive
outcome.
Methods: Our cardiac surgery database identified 100 patients undergoing surgical repair of total anomalous pul-
monary venous connection (1990–2008): supracardiac (52), cardiac (15), infracardiac (23), and mixed (10). The
median age at repair was 14.6 days (range, 0–4 years), and the median weight was 3.5 kg (range, 1.3–15 kg).
Patients were divided into 2 groups: biventricular (n ¼ 83) or single-ventricle (n ¼ 17) physiology. All but 1
of the patients with single-ventricle physiology had heterotaxy syndrome (94%), and 13 of 17 patients had supra-
cardiac anatomy.
Results: There were 12 operative deaths (4 in the biventricular group [5%] and 8 in the single-ventricle group
[47%], P< .01) and 9 late deaths (6 in the biventricular group [7%] and 3 in the single-ventricle group [18%],
P< .05). Death by total anomalous pulmonary venous connection type was supracardiac (12/52; 23.1%), cardiac
(1/15; 6.7%), infracardiac (3/23; 13.0%), and mixed (5/10; 50%). Pulmonary venous obstruction was present in 22
patients in the biventricular group (27%) and in 7 patients in the single-ventricle group (41%; P ¼ .25). Mortality
was 9 of 29 (31%) in those with pulmonary venous obstruction and 12 of 71 (17%) in those with nonpulmonary
venous obstruction (P ¼ .23). Deep hypothermic circulatory arrest was used in 38 patients (27 in the biventricular
group, 32.5%; 11 in the single-ventricle group, 64.7%). Mean deep hypothermic circulatory arrest time was 31.4
10.7 minutes (P¼ not significant between groups). Median postoperative length of stay was 11 days (range, 0–281
days). Nineteen patients required reoperation for pulmonary venous stenosis (14 in the biventricular group and 5 in
the single-ventricle group. P ¼ .045); the median time to reoperation was 104 days (range, 4–753 days).
Conclusion: Patients with total anomalous pulmonary venous connection with biventricular anatomy have good
outcomes. Patients with single-ventricle anatomy have higher mortality and increased risk for pulmonary vein
stenosis requiring reoperation. Mortality is highest in patients with mixed-type total anomalous pulmonary
venous connection. (J Thorac Cardiovasc Surg 2010;139:1387-94)Supplemental material is available online.
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The Journal of Thoracic and Carchildren born with congenital heart defects.1,2 The lesion is
characterized by an abnormal drainage of the pulmonary
veins to systemic venous circulation through a persistent
embryologic connection. Without surgical correction,
TAPVC leads to greater than 78% mortality during the first
year.3 Mortality rates after surgical correction of TAPVC
have improved with advances in surgical technique and med-
ical management; however, repair does remain a challenge
with early mortality reported in the literature at rates ranging
from less than 10% to 50%.1,4,5 Not surprisingly, isolated
TAPVC in a patient with biventricular (BV) anatomy,
without severe concomitant cardiac defects, is associated
with the best prognosis.1,4 Infants with single-ventricle (SV)
physiology and infants with heterotaxy syndrome are partic-
ularly high-risk groups.1,4 Reports of morbidity after TAPVC
surgery are highly variable and include arrhythmias,
pulmonary hypertension, and residual pulmonary venous
obstruction.4,6 Pulmonary vein obstruction, either within the
pulmonary veins or at the anastomotic site, remains an issue
in 10% to 20% of most series. In light of the variability indiovascular Surgery c Volume 139, Number 6 1387
Abbreviations and Acronyms
BV ¼ biventricular
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermic circulatory arrest
PDS ¼ polydioxanone
SV ¼ single ventricle
TAPVC ¼ total anomalous pulmonary venous
connection
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Dthe literature, a retrospective review of all patients undergoing
repair of TAPVC since 1990 at Children’sMemorial Hospital
was performed. The purpose of the studywas to determine the
outcomes after repair and identify trends and possible
predictors of the outcomes.PATIENTS AND METHODS
The institutional review board at Children’s Memorial Hospital, Chi-
cago, Illinois, approved this retrospective study and granted a waiver of in-
formed consent on February 4, 2007. We identified patients via the
computerized database for cardiac surgical patients at Children’s Memorial
Hospital, which was established in 1990. Hospital and clinic charts were re-
viewed to confirm entries; operative notes, catheterization reports, and echo-
cardiograms were reviewed.
Potential predictors of operative outcome that were evaluated included
BV versus functional SV anatomy, heterotaxy versus non-heterotaxy,
TAPVC anatomic type, preoperative pulmonary venous obstruction, use
of deep hypothermic circulatory arrest (DHCA) versus continuous cardio-
pulmonary bypass (CPB), and year/era of surgical repair. The primary out-
come measures evaluated were operative and late mortality and reoperation
for pulmonary venous stenosis, as well as time-to-mortality and time to
reoperation. Preoperative pulmonary venous obstruction was defined as in-
trinsic or extrinsic narrowing of the anomalous pulmonary venous channel
or obstruction at the interatrial septum.7 Operative mortality was defined as
death within 30 days of an operation or within the primary hospitalization.8
Long-term survival analysis was completed using date of death or date of
last follow-up at Children’s Memorial Hospital. Total elapsed time since
surgery was calculated until the end of study (December 21, 2008).
Follow-up echocardiogram data were analyzed in patients for whom echo-
cardiograms were available more than 1 month after their repair. Data from
the most recent echocardiogram were reviewed by a single echocardiog-
rapher. Every effort was made to obtain the original study tape for review;
in cases in which the tape was not available, the echocardiography report
was reviewed. Maximal gradient was measured at the level of the pulmo-
nary venous confluence to the left atrium.
Patient Demographics
Between the years 1990 and 2008, 100 patients underwent repair of
TAPVC at Children’s Memorial Hospital. All patients who underwent
TAPVC repair during this time period were included in the analysis. Patient
characteristics are summarized in Table 1. Of the 17 patients with SV anat-
omy, 16 (94%) had heterotaxy syndrome. Two of the 83 patients with BV
anatomy had heterotaxy syndrome (2.4%). All patients with heterotaxy had
right-sided isomerism with asplenia. Mean CPB time differed significantly
between groups: 86.2  31.0 minutes in the BV group versus 139.4  53.3
minutes in the SV group (P<.01). Mean aortic crossclamp time was similar
between groups: 43.9  22.4 minutes in the BV group versus 37.3  26.8
minutes in the SV group (P¼ not significant). DHCAwas used in 27 patients1388 The Journal of Thoracic and Cardiovascular Surin the BV group (32.5%) and in 11 patients in the SV group (64.7%); there
was no difference in mean DHCA time between groups (P¼ not significant).
Surgical Technique
Patients were repaired with either continuous CPB andmild hypothermia
(28C) or DHCA (18C). Crossclamp with cold-blood cardioplegia was
used for myocardial protection in all cases. The selection of continuous
CPB versus DHCA was primarily based on the complexity of the repair
with a tendency toward more frequent use of DHCA for the more complex
repairs. The vertical veinwas ligated in all cases just before opening the com-
mon pulmonary vein. For the patient with normal situs, the heart was re-
tracted out of the left chest toward the patient’s right shoulder (Figure E1).
An incision was made in the anterior surface of the common pulmonary
vein in the posterior pericardium. A mirror counter incision was made in
the posterior aspect of the left atrial appendage. Through this opening in
the left atrium, the atrial communication was visualized and closed with Pro-
lene. An anastomosis was created between the orifice in the posterior aspect
of the left atrium and the common pulmonary vein (Figure E2). The suture
material for this technique was 6.0 or 7.0 Prolene (n¼ 80) or polydioxanone
(PDS) suture (n ¼ 8) (not described, n ¼ 12). Nitric oxide was used fre-
quently in the more recent era (past 10 years). In elective or semi-urgent
cases, transesophageal echocardiography was used selectively and carefully
in the operating room with the realization that compression of the common
pulmonary vein and postoperative confluence was a potential problem. One
patient had a cardiac arrest on the induction of anesthesia (no transesopha-
geal echocardiogram probe used) and underwent cardiopulmonary resusci-
tation while being cannulated. That patient survived.
Statistical Analysis
CPB time, aortic crossclamp time, and DHCA time were compared using
t tests. For BV versus SV groups, the rates of operative death, late death, and
reoperation were compared using Fisher’s exact test. In Tables 2 and 3,
patient variables possibly associated with time to death or time to
reoperation were examined using Cox proportional hazard modeling. In
Figure 1, Kaplan–Meier curves for BV and SV time to death are presented.
Analysis was performed using SAS 9.1 (SAS Institute, Inc, Cary, NC).RESULTS
Operative and Late Mortality
There were 12 operative deaths (12/100, 12%; 4 in the
BV group [5%] vs 8 in the SV group [47%], P< .01) and
9 late deaths (9/88, 10%; 6 in the BV group [7%] vs 3 in
the SV group [18%], P< .05). Death by TAPVC type
was supracardiac (12/52; 23.1%), cardiac (1/15; 6.7%),
infracardiac (3/23; 13.0%), and mixed (5/10; 50%). Preop-
erative pulmonary venous obstruction was present in 9 of the
patients who died (9/21, 43%); therefore, of the 29 patients
who had preoperative pulmonary venous obstruction, mor-
tality was 9 of 29 (31%) versus 12 of 71 patients (17%)
with unobstructed veins (P ¼ .23). Time to death ranged
from 0 days to 3.8 years; 17 of 21 deaths (81% of deaths)
occurred within 4 months after surgery. These results are
summarized in Figure E3.
Patient variables possibly associated with time to mortality
are summarized in Table 2. Functional SV anatomy,
heterotaxy syndrome, mixed-type TAPVC, CPB time, and
use of DHCA were significantly associated with earlier time
to mortality, and pulmonary atresia trended toward
significance. Higher weight at surgery was found to havegery c June 2010
TABLE 1. Characteristics of patients who underwent TAPVC surgical repair at Children’s Memorial Hospital (1990–2008)
Patient characteristics
Value
All patients
Value Patients
with BV anatomy
Value Patients
with SV anatomy
Age at time of operation, median (range) 14.6 d
(0–4 y)
14.6 d
(0–1.7 y)
14.6 d
(0–4 y)
Weight, median (range) 3.5 kg
(1.3–15 kg)
3.5 kg
(1.3–10 kg)
3.2 kg
(1.9–15 kg)
Height, median (range) 52 cm
(40.5–150 cm)
52 cm
(40.5–150 cm)
57 cm
(45–112 cm)
Gender
Female 42 31 11
Male 58 52 6
TAPVC anatomic type
Supracardiac (type 1) 52 39 13
Cardiac (type 2) 15 15 0
Infracardiac (type 3) 23 21 2
Mixed (type 4) 10 8 2
Ventricular anatomy and diagnoses
SV 17 – 17
Heterotaxy 18 2 16
Pulmonary atresia 8 1 7
Pulmonary coarctation 7 1 6
Preoperative PV obstruction 29 22 7
Previous cardiac operations
Norwood procedure 1 0 1
PDA ligation 3 1 2
Pulmonary arterioplasty 1 0 1
Pulmonary artery band 1 0 1
Systemic-to-pulmonary artery shunt 6 1 5
Concomitant cardiac procedures at TAPVC repair
Aortic arch repair 2 1 1
Arrhythmia ablation and excision 1 0 1
Bidirectional Glenn 4 0 4
DORV intraventricular tunnel repair 1 1 0
Epicardial pacemaker placement 1 0 1
Extracardiac Fontan 1 0 1
Mitral and tricuspid valvuloplasty 1 1 0
Norwood procedure 1 0 1
VSD closure 1 1 0
Pulmonary arterioplasty 9 2 7
Pulmonary artery banding 1 0 1
Pulmonary artery debanding 1 0 1
Removal of PV stents 1 0 1
Systemic-to-pulmonary artery shunt 7 1 6
CPB time, mean 95.1  40.5 min 86.2  31.0 min 139.4  53.3 min
DHCA time, mean 31.4  10.7 min
(n ¼ 38)
31.0  14.6 min
(n ¼ 27)
31.5  8.8 min
(n ¼ 11)
Aortic crossclamp time, mean 42.9  23.1 min 43.9  22.4 min 37.3  26.8 min
Length of stay, median (range) 11 d (0–281 d) 11 d (0–281 d) 12 d (0–104 d)
BV, Biventricular; CPB, cardiopulmonary bypass;DHCA, deep hypothermic circulatory arrest; DORV, double outlet right ventricle; PDA, patent ductus arteriosus; PV, pulmonary
vein; SV, single ventricle; TAPVC, total anomalous pulmonary venous connection; VSD, ventricular septal defect.
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Da protective effect. Age, gender, preoperative pulmonary ve-
nous obstruction, prior systemic to pulmonary artery shunt,
aortic crossclamp time, and era of operative repair were not
significantly associated with time to mortality. There was no
change over time in the frequency of the type of patients re-
paired (SV vs BV). The clinical course and cause of death inThe Journal of Thoracic and Carpatients with SV anatomy who died are summarized in
Table 4.
Reoperation for Pulmonary Venous Stenosis
Nineteen patients required reoperation for pulmonary ve-
nous stenosis (14 in the BV group vs 5 in the SV group,diovascular Surgery c Volume 139, Number 6 1389
TABLE 2. Association of patient variables with overall mortality
Variable
P
value
Hazard
ratio
95%
confidence
interval
Age .25 0.25 0.024–2.60
Weight* .028 0.55 0.32–0.94
Gender (female) .35 1.51 0.64–3.56
SV* <.0001 7.34 3.11–17.35
Heterotaxy* <.0001 6.85 2.90–16.18
Pulmonary atresia .077 2.67 0.90–7.97
Mixed-type TAPVC* .0077 3.95 1.44–10.85
Preoperative PV obstruction .23 1.70 0.71–4.03
Prior systemic-to-pulmonary artery shunt .51 1.64 0.38–7.03
CPB time* .016 1.01 1.00–1.02
Aortic crossclamp time .21 1.01 0.99–1.03
Use of DHCA* .0010 6.35 2.10–19.16
Era of repair, compared with present era
(2002–2008)
1990–1995 .92 0.95 0.40–2.46
1996–2001 .24 0.46 0.13–1.66
CPB, Cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; PV, pul-
monary vein; SV, single ventricle; TAPVC, total anomalous pulmonary venous con-
nection. *Statistically significant.
FIGURE 1. Kaplan–Meier curve showing the time to death after initial
repair.
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DP¼ .045). There were 23 reoperations; 2 patients underwent
2 reoperations each (1 survived, 1 late death), and 1 patient
underwent 3 reoperations (survived). The median time to
initial reoperation was 104 days (range, 4–753 days). Fifteen
of the 19 reoperations (79%) occurred within the first 6
months after primary TAPVC repair. Patient variables pos-
sibly associated with time to reoperation are summarized
in Table 3. Only functional SV anatomy and heterotaxyTABLE 3. Association of patient variables with reoperation
Variable
P
value
Hazard
ratio
95%
confidence
interval
Age .99 1.01 0.28–3.72
Weight 1.00 1.00 0.76–1.31
Gender (female) .12 2.07 0.83–5.16
SV* .045 2.86 1.02–8.00
Heterotaxy* .051 2.79 1.00–7.82
Pulmonary atresia .16 2.43 0.71–8.36
Mixed-type TAPVC .55 1.56 0.36–6.74
Preoperative PV obstruction .48 1.40 0.55–3.56
Prior systemic-to-pulmonary artery shunt .49 1.68 0.39–7.31
CPB time .19 1.01 1.00–1.02
Aortic crossclamp time .94 1.00 0.98–1.03
Use of DHCA .31 1.60 0.65–3.94
Era of repair, compared with present era
(2002–2008)
1990–1995 .61 0.75 0.25–2.25
1996–2001 .66 0.78 0.26–2.35
CPB, Cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; PV, pul-
monary vein; SV, single ventricle; TAPVC, total anomalous pulmonary venous con-
nection. *Statistically significant.
1390 The Journal of Thoracic and Cardiovascular Sursyndrome were associated with earlier time to reoperation.
Eight patients had PDS for the anastomosis with no reoper-
ations for pulmonary vein stenosis, no operative mortality,
and 2 late deaths. Eighty patients had Prolene for the anasto-
mosis with 16 reoperations for pulmonary vein stenosis
(much longer follow-up), 9 operative deaths, and 4 late
deaths. A comparison of Prolene with PDS showed reopera-
tion P ¼ .34, operative mortality P ¼ 1.0, and late mortality
P ¼ .11. This seems to come out as mildly in favor of PDS,
although it is not statistically significant.
Long-Term Follow-up
The mean time to follow-up in our series was 4.21 5.20
years (range, 1 month to 18.6 years). The mean elapsed time
since surgery (maximum possible follow-up) was 7.71 6.5
years (range, 0–18.6 years). Follow-up time was 55% of the
total elapsed time since surgery. Kaplan–Meier curves of SV
and BV groups are shown in Figure 1.
Echocardiographic follow-up data were available for 65
patients. Median length of echocardiographic follow-up
time was 46 months (range, 1 month to 17.7 years). For
20 of 65 patients, the original study was not available, but
a report was available; the mean gradient was reported as un-
obstructed, mild, moderate, or severe. For these 65 patients
the mean gradient was converted to a categoric variable as
follows: unobstructed,<2.5 mm Hg; mild, 2.5–5 mm Hg;
moderate, 5–10 mm Hg; severe,>10 mm Hg. This resulted
in 43 of 65 patients (66.2%) classified with no obstruction,
10 of 65 patients (15.4%) classified with mild obstruction, 8
of 65 patients (12.3%) classified with moderate obstruction,
and 4 of 65 patients (6.2%) classified with severe obstruc-
tion (Figure E4). The patients with severe obstruction either
had a reoperation or died of complex medical issues. Of the
45 patients in whom numeric measurements of the mean gra-
dient were available, the median value for the mean gradient
was 1.7 mm Hg (range, 0.6–15 mm Hg).gery c June 2010
TABLE 4. Mortality in patients with single-ventricle anatomy and total anomalous pulmonary venous connection
Patient Diagnosis Operative repair Mortality (time since repair) Cause of death
1 2-day-old male patient with
heterotaxy, pulmonary atresia,
supracardiac TAPVC,
pulmonary coarctation, PDA;
on prostaglandin drip to
maintain PA blood flow, on
ventilator
TAPVC repair, pulmonary
arterioplasty, SP shunt, atrial
septectomy, PDA ligation,
DHCA
Operative (77 d);
s/p surgical wound drainage
33; s/p central venous access
Sepsis
2 28-day-old female patient with
heterotaxy, unbalanced AVC,
mixed TAPVC, PV
obstruction; on ventilator;
s/p SP shunt
TAPVC repair, DHCA Operative (2 d) Low cardiac output
3 14-day-old female patient with
heterotaxy, unbalanced AVC,
DORV, pulmonary stenosis,
supracardiac TAPVC, PDA
(on prostaglandin drip), on
ventilator
TAPVC repair, atrial septectomy,
PDA ligation, SP shunt, DHCA
Operative (32 d);
s/p pericardial drainage, central
venous access; s/p delayed
sternal closure; s/p
thrombectomy of SP shunt
Low cardiac output
4 1-day-old female patient with
heterotaxy, infracardiac
TAPVC, PV obstruction, PDA;
on ventilator
TAPVC repair, PDA ligation,
central venous access, DHCA
Operative (71 d)
s/p delayed sternal closure;
s/p surgical wound drainage x2
Sepsis, cardiac tamponade,
ventilator dependent
5 12-day-old male patient with
heterotaxy, DORV, mitral
atresia, hypoplastic aortic arch,
supracardiac TAPVC, PV
obstruction, presented in
extremis with pH 7.1
TAPVC repair, atrial septectomy,
PA band, aortic arch repair with
extended end-to-end
anastomosis, DHCA
Operative (died in operating
room)
Cardiac failure
6 82-day-old female patient with
heterotaxy, unbalanced AVC,
situs inversus, bilateral SVC,
supracardiac TAPVC, PV
obstruction; s/p PDA ligation,
PA band; on ventilator
TAPVC repair, removal of 3 stents
retained in atrium, DHCA, TEE
Late (3.8 y)
s/p bidirectional Glenn, PV
stenosis repair; s/p second PV
stenosis repair, mitral
valvuloplasty, pacemaker
Low cardiac output
Died 1 mo after second PV
stenosis repair
7 35-day-old female patient with
heterotaxy, mitral atresia,
DORV, Scimitar syndrome
(hypoplastic R lung with
systemic arterial supply), COA,
supracardiac TAPVC, PV
obstruction; s/p duodenal
atresia repair
Norwood–Sano procedure,
TAPVC repair, DHCA
Operative (2 d) Low cardiac output;
postoperative cardiac arrest
8 0-day-old female patient with
heterotaxy, pulmonary atresia,
discontinuous PA, supracardiac
TAPVC, PV obstruction,
bilateral PDA, transposition,
common atrioventricular canal;
on ventilator
TAPVC repair, anastomosis of R
and L PA, SP shunt, bilateral
PDA ligation, DHCA
Operative (104 d);
s/p delayed sternal closure; s/p
chest tube for pleural effusion
Multisystem organ failure,
sclerosing venitis, ventilator
dependent
(Continued)
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DDISCUSSION
We reviewed our results with infants undergoing surgical
repair of TAPVC at a single institution over a 20-year
period. Our experience is somewhat unique in that allThe Journal of Thoracic and Carpatients were operated on by 2 surgeons using virtually iden-
tical techniques. The primary surgical strategy was a direct
anastomosis between the left atrium and the common
pulmonary vein retracting the apex of the heart toward thediovascular Surgery c Volume 139, Number 6 1391
TABLE 4. Continued
Patient Diagnosis Operative repair Mortality (time since repair) Cause of death
9 9-day-old female with heterotaxy,
DORVwith transposition, situs
inversus, common
atrioventricular valve,
pulmonary stenosis, PDA,
bilateral SVC, supracardiac
TAPVC, atrial tachycardia
TAPVC repair, SP shunt, PDA
ligation, SVT ablation and
excision, DHCA
Late (157 d);
s/p PA plasty and SP shunt32;
s/p PV stenosis repair, mitral
valvuloplasty, bilateral
bidirectional Glenn (operative
mortality)
Low cardiac output, complex
anatomy, recurrent PV stenosis
10 3-day-old male patient with
heterotaxy, transposition,
pulmonary atresia, pulmonary
coarctation, atrioventricular
canal, PDA, bilateral SVC,
infracardiac TAPVC,
prematurity (1.9 kg)
TAPVC repair, SP shunt,
pericardial patch repair of
pulmonary coarctation, DHCA
Operative (died in operating
room)
Low cardiac output
11 1-year-old male patient with
unbalanced AVC, mixed
TAPVC; s/p Norwood, s/p SP
shunt revision
TAPVC repair, bidirectional
Glenn
Late (62 d);
s/p PV stenosis repair,
bidirectional Glenn
Sudden death at home, family
declined autopsy
AVC, Atrioventricular canal; AVNRT, atrioventricular nodal reentry tachycardia; COA, coarctation; DHCA, deep hypothermic cardiac arrest; DORV, double-outlet right ventricle;
PDA, patent ductus arteriosus; PA, pulmonary artery; PV, pulmonary vein; SP, systemic-to-pulmonary; SVC, superior vena cava; SVT, supraventricular tachycardia; TAPVC, total
anomalous pulmonary venous connection; TEE, transesophageal echocardiogram.
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Dpatient’s right shoulder. We analyzed these patients to look
for risk factors for mortality and reoperation from anasto-
motic stenosis. We also looked at patient covariables to
determine which were associated with adverse outcomes.
Our primary findings were that patients with BV anatomy
have excellent outcomes and a low incidence of reoperation
for anastomotic or pulmonary vein stenosis. In contrast, pa-
tients with functional SV anatomy, nearly all of whom in our
series also had heterotaxy syndrome (right isomerism), have
a significantly increased operative and late mortality and are
at increased risk for reoperation from anastomotic stricture
and pulmonary vein stenosis. On the basis of the morphol-
ogy of the anomalous pulmonary venous connection in our
series, the mortality was highest for those with a mixed-
type connection.
Our analysis focused on comparing the outcomes in pa-
tients with BV anatomy versus those with functional SV
anatomy. The patients with functional SV (94% heterotaxy)
anatomy had late pulmonary vein or anastomotic stenosis in
41% of the cases. The CPB times were significantly longer
in the SV group, and the use of DHCA was nearly twice as
common in the patients with functional SV anatomy. Risk
factors that were associated with increased mortality in-
cluded low patient weight, functional SV, heterotaxy syn-
drome, mixed-type TAPVC, longer CPB time, and use of
DHCA. Patients with functional SV anatomy frequently
had other associated anomalies, such as pulmonary atresia,
pulmonary coarctation, and unbalanced atrioventricular ca-
nal defect. These patients all required other procedures and
had longer CPB runs and required DHCA. In carefully ex-
amining all of the patients with a functional SV and TAPVC,1392 The Journal of Thoracic and Cardiovascular Surthe causes of death seem to be in 2 main categories. Approx-
imately 50% of those patients died of low cardiac output
either in the immediate perioperative period or within the
first month after the operation. The other 50% died of com-
plications of sepsis and multisystem organ failure from
prolonged hospitalization and ventilation. These patients
with right isomerism (asplenia) are at increased risk for sep-
sis. It is likely that the difficulty in balancing pulmonary and
systemic blood flow in this complex patient group with a sys-
temic single right ventricle was also a significant contributor
to the deaths in both groups.
Similar findings were noted in the series from Children’s
Hospital Boston reported by Hancock Friesen and col-
leagues.4 In that series, 32% of the patients had SV anat-
omy. The mortality in the SV group at 36 months was
53% versus 13% for the patients with 2 ventricles. That
series also concluded that pre-repair pulmonary venous ob-
struction was a multivariate risk factor for death. In our se-
ries, pulmonary vein obstruction was more common in the
patients who died, but this did not reach the level of statisti-
cal significance. The review by Lodge and associates,9 from
the Children’s Hospital of Philadelphia, reached a similar
conclusion regarding patients with functional SV anatomy
and TAPVC. Although the early survival of these patients
had improved in recent years, the intermediate survival
was still 50%. In their series, whether the veins were
obstructed or not did not affect early survival. Five of the pa-
tients in this series required heart or heart-lung transplanta-
tion. In Caldarone and colleagues’10 review of patients at
the Hospital for Sick Children, the mortality for complex
cases remained constant at 52%.gery c June 2010
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DThe exception to this is a recent series from Texas Chil-
dren’s Hospital published by Morales and colleagues,11
which did show improvement in these complex patients
with SV and heterotaxy. Their 5-year survival for patients
with heterotaxy was 79% compared with 89% for patients
without heterotaxy. These results are significantly better
than the results reported in our series and others, although
they continue to show a 10% differential between the
2 groups. The majority of their reoperations were also for
patients with heterotaxy syndrome. They also found that
the rate of pulmonary vein reoperation was statistically
greater for patients with heterotaxy than for patients without
heterotaxy. By using Cox’s proportional hazard model, the
authors reported that pulmonary atresia and the need for
a systemic pulmonary artery shunt were risk factors for
death. In the discussion of that presentation many surgeons
noted that these results were dramatically different and better
than most reported series. One of the answers addressing this
issue was that the Texas Children’s Hospital has used a mul-
tidisciplinary team to care for patients with heterotaxy syn-
drome. With these excellent results, some time should be
spent evaluating the technical details of their procedure.
They limited dissection to the confluence of the pulmonary
veins with minimal manipulation of the pulmonary veins.
They advocated small endocardial to endothelial bites min-
imizing the thickness of the anastomosis. They used a tech-
nique similar to ours with exposure of the confluence by
lifting the apex of the heart toward the right shoulder and
creating an extracardiac anastomosis when possible. They
preferred to perform the anastomosis under circulatory arrest
to optimize visualization and accuracy.
In the majority of patients, we used the technique of elevat-
ing the apex of the heart toward the right shoulder, creating an
extracardiac anastomosis between the common pulmonary
vein and the left atrium. The exception to this was in the pa-
tients with coronary sinus TAPVC. For these patients, we
used a technique similar to that originally described by van
Praagh and associates,12 that is, cutting back the coronary
sinus, widely opening the atrial septal defect, and performing
a pericardial patch closure of the combined orifices of the
coronary sinus and the now enlarged atrial septal defect.
Our mortality was lowest (6.7%) in this group of patients.
The highest mortality (50%) was observed in the patients
with mixed-type TAPVC. The difficulties in patients with
mixed TAPVC were reported by Delius and colleagues13
from Great Ormond Street. The recent review by Chowdhury
and associates14 from the All India Institute revealed that the
risk of death was 5.8 times higher in patients with category III
of mixed TAPVC.
One of the issues recently raised in the surgical literature is
whether or not the vertical vein should be ligated at the time
of total anomalous pulmonary venous repair. Chowdhury
and colleagues15 noted a higher operative mortality in pa-
tients who had their vertical vein ligated. They recommendedThe Journal of Thoracic and Carthe use of an adjustable ligature around the vertical vein in
patients with more than moderate post-bypass pulmonary
hypertension. Their article was the subject of an editorial
by Dr Tweddell, who questioned this strategy.16 We ligated
the vertical vein in all of our patients andwere able tomanage
their postoperative pulmonary hypertension with nitric oxide
therapy and conventional ventilator management strategies.
Our technique was associated with approximately 20% of
the patients requiring reoperation for pulmonary vein steno-
sis. Reoperation for pulmonary vein or anastomotic stenosis
was more common in the patients with a functional SV than
those with BV anatomy. Most of these reoperations occurred
within 6 months of surgery. The primary technique used to
repair the patients with pulmonary vein stenosis was the
sutureless technique, previously described by Caldarone
and colleagues17 and Lacour-Gayet and colleagues.18 In
evaluating patient variables that were risk factors for reoper-
ation, the only statistically significant associations were
functional SV and heterotaxy syndrome.Wewere somewhat
disappointed that the era of repair did not result in an im-
provement in the reoperation rate for anastomotic stenosis.
The distribution of patients with more complex SV anatomy
was constant during the study period and did not factor into
any significant era effects. Hawkins and associates19 previ-
ously reported that the use of an absorbable suture was asso-
ciated with a reduced incidence of anastomotic stenosis.
Although we did not have enough patients with absorbable
suture (n ¼ 8) to make a definitive comparison, our results
are mildly in favor of the use of an absorbable suture such
as PDS.
The majority of the patients who have had long-term fol-
low-up echocardiograms have a low gradient at the pulmo-
nary vein anastomosis. The median value for the gradient
at the anastomosis was 1.7 mm Hg, with a median follow-
up of 46 months. Because significant restenosis requiring
reoperation occurred within 6 months of surgery in the ma-
jority of patients, we believe that a 46-month follow-up time
is acceptable to demonstrate good intermediate-term results.
CONCLUSIONS
The outcomes of patients with TAPVC seem to have a di-
chotomous distribution. The patients with BV anatomy, no
associated significant cardiac anomalies, and unobstructed
pulmonary veins have a low operative mortality and excel-
lent long-term outcome with a low incidence of anastomotic
or pulmonary vein stenosis using the technique we have de-
scribed. However, in patients with functional SV anatomy,
nearly all had associated heterotaxy syndrome (right atrial
isomerism, asplenia), a high operative and late mortality,
and a high incidence of reoperation for anastomotic or pul-
monary vein stenosis. For these patients with heterotaxy
syndrome with SV physiology, we must focus on more care-
ful balancing of the pulmonary and systemic circulation and
careful avoidance of postoperative bloodstream and otherdiovascular Surgery c Volume 139, Number 6 1393
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Dinfections. In these patients, there is little margin for error
regarding either of these 2 issues given their overall marginal
cardiac output. There is clearly room for improvement in
our management strategies for this patient population. Un-
fortunately, it does seem that patients with a combination
of right atrial isomerism with a functional SV and obstruc-
tion of the anomalous pulmonary veins with the potential
for sepsis, given the associated asplenia, are a formidable
and challenging group.References
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FIGURE E1. Patient who has supracardiac TAPVC and is on CPB with bicaval venous cannulation. The aorta has been crossclamped, and cold blood
cardioplegia has been delivered. The surgeon is standing on the left side of the table, and the assistant is retracting the apex of the heart toward the right shoul-
der of the patient. The inferior vena cava and superior vena cava have been snared. The dotted lines indicate the 2 incisions to bemade: 1 in the left atrium and 1
in the common pulmonary vein. There is a snare around the vertical vein that is superior to the left pulmonary artery. The vertical vein is ligated just before
opening the common pulmonary vein. Reprinted with permission: Mavroudis C, Backer CL, eds. Pediatric Cardiac Surgery. 3rd ed. Philadelphia, PA:
Mosby, Inc; 2003. LV, Left ventricle; LAA, left atrial appendage; Ao, aorta; LPA, left pulmonary artery; VV, vertical vein; IVC, inferior vena cava; RPV, right
pulmonary vein; LLPV, left lower pulmonary vein; LUPV, left upper pulmonary vein.
Kelle et al Congenital Heart Disease
The Journal of Thoracic and Cardiovascular Surgery c Volume 139, Number 6 1394.e1
C
H
D
FIGURE E2. An anastomosis performed in a parachute-type fashion between the left atrium and the common pulmonary vein. In most patients, a widely
patent anastomosis such as this can be achieved. Note that the incision in the common pulmonary vein does not extend into the branches of the pulmonary
veins themselves. The vertical vein has been ligated. Reprinted with permission: Mavroudis C, Backer CL, eds. Pediatric Cardiac Surgery. 3rd ed. Mosby,
Inc; 2003. LAA, Left atrial appendage; LPA, left pulmonary artery; VV, vertical vein; IVC, inferior vena cava; LLPV, left lower pulmonary vein; LUPV, left
upper pulmonary vein.
FIGURE E3. Flow tree summarizes the outcomes of patients with BV and functional SV anatomy. TAPVC, Total anomalous pulmonary venous connection;
BV, biventricular; SV, single ventricle.
Congenital Heart Disease Kelle et al
1394.e2 The Journal of Thoracic and Cardiovascular Surgery c June 2010
C
H
D
FIGURE E4. Chart showing the gradient at pulmonary vein anastomosis.
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